Our mission is to build an intelligent clinical-development platform where human teams, AI agents, and unified clinical data work together in a secure collaborative layer that accelerates every phase of a trial from protocol design to patient outcomes.
We believe that clinical trials are too important and too urgent to be slowed by manual processes and fragmented data. The pharmaceutical industry needs AI that doesn't just assist;it acts. AI that understands regulatory requirements, synthesizes complex data, and makes intelligent decisions at the speed of software.
We're not building tools for incremental improvement. We're building a new operating system for clinical trial startup;one that will fundamentally change how quickly new medicines reach patients who need them.
Patient-First: Every decision we make prioritizes the patients who need new treatments
Speed Without Compromise: Accelerate trials while maintaining the highest quality standards
Transparent AI: Our AI systems are explainable, auditable, and trustworthy
Collaboration Over Competition: Partner with the entire clinical research ecosystem
Continuous Innovation: Never stop improving, learning, and pushing boundaries
FAQ
Keep exploring
Meet the people building Kitsa's AI-native infrastructure for clinical development.
Four pervasive AI misconceptions in clinical trials that derail programs, inflate costs, and create regulatory exposure, with evidence on what the data actually shows.
Before selecting an AI patient screening tool for clinical trial recruitment, ask these 7 critical questions to avoid costly mismatches and protocol failures.
Before buying AI regulatory software for clinical trials, sponsors need answers on validation, audit trails, hallucination controls, and GCP compliance. Here are the 9 essential questions.